Japan’s Plan to Recommend Drug for Coronavirus Sees FujiFilm Shares Soar
This article is for subscribers only.
Fujifilm Holdings Corp. rose as much as 8.8% following Japanese Health Minister Katsunobu Kato’s comments over the weekend on the country’s plans to recommend its Avigan drug to treat coronavirus.
That compared to Japan’s benchmark Topix index, which slumped as much as 4.2%, the most since December 2018, on escalating concern over the global coronavirus outbreak. Japan markets were closed on Monday for a public holiday.